Francesco Paolo Caronia1, Alfonso Fiorelli2, Enrico Ruffini3, Maurizio Nicolosi4, Mario Santini2, Attilio Ignazio Lo Monte5. 1. Istituto Oncologico del Mediterraneo, Viagrande, Catania, Italy fpcaronia@yahoo.it. 2. Unità Operativa di Chirurgia Toracica, Seconda Università di Napoli, Napoli, Italy. 3. Unità Operativa di Chirurgia Toracica, Università di Torino, Torino, Italy. 4. Chirurgia Toracica, Ospedale Cannizzaro, Catania, Italy. 5. Dipartimento di Chirurgia 'GENURTO', Università di Palermo, Palermo, Italy.
Abstract
OBJECTIVES: The aim of the present paper was to conduct a comparative analysis of outcomes after thoracoscopic resection versus standard thoracotomy approach in the treatment of Pancoast tumours. METHODS: All consecutive patients with Pancoast tumours undergoing surgical treatment from March 2000 to November 2012 were enrolled. Patients were divided into 2 groups according to whether a thoracoscopic or standard thoracotomy approach was adopted. In addition to morbidity and mortality, (i) intensity of pain; (ii) respiratory function focusing on the postoperative value and its variation with respect to the predicted value (Delta); (iii) analgesic consumption at different times during the postoperative course; and (iiii) survival rate were recorded in both groups and the inter-group differences were statistically compared. RESULTS: Of the 45 enrolled patients, 34 (75%) were included in the final analysis (18 in the thoracoscopic group and 16 in the standard group). Eleven (25%) patients were excluded because they (i) were unfit for surgery after induction therapy (n = 4); (ii) refused the operation (n = 1) or (iii) had unexpected pleural involvement (n = 6). Compared with the standard group, in the thoracoscopic group we observed less pain (P = 0.01), better recovery of forced vital capacity (P = 0.01) and forced expiratory value in 1 s (P < 0.001), and a reduction in opioid (P = 0.01) and analgesic consumption (P = 0.02). The median survival for all patients was 15 months. Patients with N0/N1 disease had better median survival than N2 patients (47 vs 9 months; P = 0.009). One local recurrence in the standard group was observed 1 year after operation, whereas 2 local recurrences, 1 in the thoracoscopic group and another in the standard group, were registered 2 years after the operation (P = 1.0). Finally, 4 (22%) extrathoracic metastases in the thoracoscopic group and 5 (31%) in the standard group (P = 0.8) were found over the 2 years following the procedure. CONCLUSIONS: In the management of Pancoast tumours, a thoracoscopic approach is safe and may be an effective adjunct to standard surgical resection in selected cases. Such an approach enabled surgeons to explore the pleural cavity and avoid exploratory thoracotomy in cases of unexpected pleural involvement.
OBJECTIVES: The aim of the present paper was to conduct a comparative analysis of outcomes after thoracoscopic resection versus standard thoracotomy approach in the treatment of Pancoast tumours. METHODS: All consecutive patients with Pancoast tumours undergoing surgical treatment from March 2000 to November 2012 were enrolled. Patients were divided into 2 groups according to whether a thoracoscopic or standard thoracotomy approach was adopted. In addition to morbidity and mortality, (i) intensity of pain; (ii) respiratory function focusing on the postoperative value and its variation with respect to the predicted value (Delta); (iii) analgesic consumption at different times during the postoperative course; and (iiii) survival rate were recorded in both groups and the inter-group differences were statistically compared. RESULTS: Of the 45 enrolled patients, 34 (75%) were included in the final analysis (18 in the thoracoscopic group and 16 in the standard group). Eleven (25%) patients were excluded because they (i) were unfit for surgery after induction therapy (n = 4); (ii) refused the operation (n = 1) or (iii) had unexpected pleural involvement (n = 6). Compared with the standard group, in the thoracoscopic group we observed less pain (P = 0.01), better recovery of forced vital capacity (P = 0.01) and forced expiratory value in 1 s (P < 0.001), and a reduction in opioid (P = 0.01) and analgesic consumption (P = 0.02). The median survival for all patients was 15 months. Patients with N0/N1 disease had better median survival than N2 patients (47 vs 9 months; P = 0.009). One local recurrence in the standard group was observed 1 year after operation, whereas 2 local recurrences, 1 in the thoracoscopic group and another in the standard group, were registered 2 years after the operation (P = 1.0). Finally, 4 (22%) extrathoracic metastases in the thoracoscopic group and 5 (31%) in the standard group (P = 0.8) were found over the 2 years following the procedure. CONCLUSIONS: In the management of Pancoast tumours, a thoracoscopic approach is safe and may be an effective adjunct to standard surgical resection in selected cases. Such an approach enabled surgeons to explore the pleural cavity and avoid exploratory thoracotomy in cases of unexpected pleural involvement.
Authors: Francesco Paolo Caronia; Ettore Arrigo; Andrea Valentino Failla; Francesco Sgalambro; Giorgio Giannone; Attilio Ignazio Lo Monte; Massimo Cajozzo; Mario Santini; Alfonso Fiorelli Journal: J Thorac Dis Date: 2018-04 Impact factor: 2.895
Authors: Francesco Paolo Caronia; Alfonso Fiorelli; Fabio Zanchini; Mario Santini; Attilio Ignazio Lo Monte; Sergio Castorina Journal: Gen Thorac Cardiovasc Surg Date: 2014-10-16
Authors: Alfonso Fiorelli; Anna Cecilia Izzo; Ettore Arrigo; Francesco Sgalambro; Maria Antonietta Lepore; Massimo Cajozzo; Sergio Castorina; Attilio Ignazio Lo Monte; Mario Santini; Francesco Paolo Caronia Journal: Ann Transl Med Date: 2018-05
Authors: Alfonso Fiorelli; Immacolata Mauro; Gaetano Cicchitto; Aldo Prencipe; Mario Polverino; Vincenzo Giuseppe Di Crescenzo; Mario Santini Journal: Ann Transl Med Date: 2019-07
Authors: Kheira Hireche; Mathieu Moqaddam; Nicolas Lonjon; Charles Marty-Ané; Laurence Solovei; Baris Ata Ozdemir; Ludovic Canaud; Pierre Alric Journal: Interact Cardiovasc Thorac Surg Date: 2021-07-30
Authors: Francesco Paolo Caronia; Alfonso Fiorelli; Ettore Arrigo; Sebastiano Trovato; Mario Santini; Attilio Ignazio Lo Monte Journal: J Cardiothorac Surg Date: 2016-11-22 Impact factor: 1.637